VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 665 filers reported holding VANECK VECTORS ETF TR in Q3 2020. The put-call ratio across all filers is 1.01 and the average weighting 0.6%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $83,027,765 | +117409.9% | 3,085,387 | +31.5% | 0.14% | +31.4% |
Q2 2023 | $70,656 | -45.8% | 2,346,601 | -41.8% | 0.10% | -50.7% |
Q1 2023 | $130,465 | +160.4% | 4,033,729 | +130.6% | 0.21% | +184.0% |
Q4 2022 | $50,110 | -99.9% | 1,749,083 | -9.3% | 0.08% | -9.6% |
Q3 2022 | $46,524,000 | -56.7% | 1,929,324 | -50.9% | 0.08% | -58.5% |
Q2 2022 | $107,468,000 | -41.9% | 3,925,892 | -18.6% | 0.20% | -28.3% |
Q1 2022 | $184,856,000 | +25.4% | 4,820,426 | +4.7% | 0.28% | +41.6% |
Q4 2021 | $147,412,000 | +29.7% | 4,602,327 | +19.3% | 0.20% | +10.7% |
Q3 2021 | $113,653,000 | -37.1% | 3,856,599 | -27.5% | 0.18% | -36.4% |
Q2 2021 | $180,784,000 | +74.4% | 5,320,318 | +66.8% | 0.28% | +53.8% |
Q1 2021 | $103,664,000 | +34.5% | 3,189,695 | +49.1% | 0.18% | +28.2% |
Q4 2020 | $77,078,000 | -4.5% | 2,139,895 | +3.8% | 0.14% | -28.3% |
Q3 2020 | $80,725,000 | +2.9% | 2,061,410 | -3.6% | 0.20% | -0.5% |
Q2 2020 | $78,459,000 | +45.8% | 2,139,011 | -8.4% | 0.20% | +21.3% |
Q1 2020 | $53,821,000 | -46.7% | 2,336,024 | -32.3% | 0.16% | -3.0% |
Q4 2019 | $100,994,000 | -39.8% | 3,449,676 | -45.1% | 0.17% | -52.1% |
Q3 2019 | $167,693,000 | -61.4% | 6,278,920 | -63.1% | 0.35% | +161.5% |
Q2 2019 | $434,406,000 | +4234.5% | 17,000,000 | +3702.9% | 0.14% | +743.8% |
Q1 2019 | $10,022,000 | -51.3% | 447,028 | -54.2% | 0.02% | -54.3% |
Q4 2018 | $20,566,000 | +13.7% | 975,205 | -0.1% | 0.04% | +6.1% |
Q3 2018 | $18,087,000 | +754.8% | 976,667 | +929.2% | 0.03% | +725.0% |
Q2 2018 | $2,116,000 | -4.2% | 94,900 | -5.6% | 0.00% | -20.0% |
Q1 2018 | $2,208,000 | -61.7% | 100,500 | -59.5% | 0.01% | -70.6% |
Q4 2017 | $5,760,000 | +16.0% | 247,871 | +14.6% | 0.02% | +6.2% |
Q3 2017 | $4,967,000 | -44.0% | 216,332 | -46.1% | 0.02% | -42.9% |
Q2 2017 | $8,868,000 | +132.2% | 401,632 | +139.9% | 0.03% | +180.0% |
Q1 2017 | $3,819,000 | +10.6% | 167,432 | +1.4% | 0.01% | 0.0% |
Q4 2016 | $3,454,000 | +5133.3% | 165,100 | +6504.0% | 0.01% | – |
Q3 2016 | $66,000 | -5.7% | 2,500 | 0.0% | 0.00% | – |
Q2 2016 | $70,000 | – | 2,500 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
New Harbor Financial Group, LLC | 1,221,955 | $36,011,000 | 14.81% |
New Harbor Financial Group, LLC | 1,155,900 | $34,064,000 | 14.01% |
Memorial Sloan Kettering Cancer Center | 738,500 | $21,764,000 | 13.56% |
Hollow Brook Wealth Management LLC | 670,275 | $19,753,000 | 12.24% |
Grand Central Investment Group | 293,243 | $8,642,000 | 11.46% |
BW Gestao de Investimentos Ltda. | 940,800 | $27,725,000 | 8.44% |
Slate Path Capital LP | 5,930,000 | $174,757,000 | 7.97% |
Nokomis Capital, L.L.C. | 512,628 | $15,107,000 | 7.14% |
Plaisance Capital LLC | 288,000 | $8,487,000 | 6.05% |
Guild Investment Management, Inc. | 200,114 | $5,897,000 | 5.68% |